ENVB Earnings

Quarterly EPS
$-44.64
Q2 2024
$-43.10
Q3 2024
$-57.46
Q4 2024
$-14.58
Q1 2025
$-11.64
Q2 2025
$-10.81
Q3 2025
$-6.13
Q4 2025
$-1.08
Q1 2026
Latest RevenueN/A
Latest Net Income-1633473
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$1.080-1633473+92.6%
Q4 2025-$6.130-2194171+89.3%
Q3 2025-$10.810-1873669+74.9%
Q2 2025-$11.640-2494708+73.9%
Q1 2025-$14.580-2184966+86.8%
Q4 2024-$57.460-3154646+78.8%
Q3 2024-$43.100-2084032+81.6%
Q2 2024-$44.640-1894046+91.8%
Q1 2024-$110.520-2456915
Q4 2023-$270.570-3435936
Q3 2023-$234.000-2822216
Q2 2023-$547.200-6356053
Enveric Biosciences (ENVB) — Earnings